Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.84 |
| ▸ | HMGCR | P04035 | 3/20 | 0.84 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.75 |
| ▸ | RECQL | P46063 | 2/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | USP2 | O75604 | 1/20 | 0.71 |
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | HPGD | P15428 | 1/20 | 0.71 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.71 |
| ▸ | PPARG | P37231 | 4/20 | 0.60 |
| ▸ | PPARD | Q03181 | 4/20 | 0.60 |
| ▸ | PPARA | Q07869 | 4/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30482565 | 1.00 | PTPN7 (0.84) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL28742886 | 1.00 | PTPN7 (0.84) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL29479497 | 1.00 | PTPN7 (0.84) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL4054025 | 1.00 | PTPN7 (0.84) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL22540047 | 1.00 | PTPN7 (0.84) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL28742730 | 1.00 | PTPN7 (0.84) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL2729816 | 1.00 | PTPN7 (0.84) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL26624825 | 1.00 | PTPN7 (0.84) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL26624511 | 0.98 | PTPN7 (0.81) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL26624871 | 0.98 | PTPN7 (0.81) | PTPN7HMGCRTDP1RECQLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| CN-115607677-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-114569726-B | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-10-28 | — | — | CN | disclosed |
| CN-114788872-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-114569726-A | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-06-03 | — | — | CN | disclosed |
| US-9149019-B2 | Method of eliminating cat urine odor | JMR, LC (US) | 2015-10-06 | — | — | US | disclosed |
| US-20130323194-A1 | METHOD OF ELIMINATING CAT URINE ODOR | CO2 TECHNOLOGIES, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| US-20070066170-A1 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2007-03-22 | — | — | US | disclosed |
| US-7189666-B2 | CO2 generating absorbent pads | CO2 TECHNOLOGIES (US) | 2007-03-13 | — | — | US | disclosed |
| WO-2005005520-A2 | ACTIVE MASTERBATCH FOR PRODUCTION OF CO2 GENERATING MASTERBATCH | CO2 TECHNOLOGIES, INC. (US) | 2005-01-20 | — | — | WO | disclosed |
| US-20050001204-A1 | Active masterbatch for production of CO2 generating masterbatch | CO2 TECHNOLOGIES, INC. (US) | 2005-01-06 | — | — | US | disclosed |
| WO-2004110876-A2 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| US-20040247750-A1 | CO2 generating absorbent pads | CO2 TECHNOLOGIES, INC. | 2004-12-09 | — | — | US | disclosed |
| US-20040219202-A1 | Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety | IMUTHES LIMITED (GB) | 2004-11-04 | — | — | US | disclosed |
| US-6797235-B2 | Device and methods for modifying an atmosphere | CO2 TECHNOLOGIES, INC. | 2004-09-28 | — | — | US | disclosed |
| EP-1411898-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPIDS WITH A POLAR AND A NONPOLAR MOIETY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-04-28 | — | — | EP | disclosed |
| WO-2004022112-A1 | DEVICE AND METHODS FOR MODIFYING AN ATMOSPHERE | CO2 TECHNOLOGIES, INC. (US) | 2004-03-18 | — | — | WO | disclosed |
| US-20040047760-A1 | Device and methods for modifying an atmosphere | LONGER SHELF LIFE, LLC | 2004-03-11 | — | — | US | disclosed |
| WO-2003011252-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPIDS COMPRISING A POLAR AND A NONPOLAR MOIETY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040219202-A1 | Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety | NCEH1, NR1H2, HMGCR | PTPN7 553/4885HMGCR 3/4885TDP1 3040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.